Vascular aspects in Alzheimer’s disease

  • Ingmar Skoog
Conference paper


Alzheimer’s disease is a primary degenerative dementia and is not considered to be of vascular origin. Furthermore, severe cerebrovascular diseases are generally exclusionary for the clinical diagnosis. During recent years both epidemiological and neuropathological studies have suggested an association between Alzheimer’s disease and several vascular risk factors, such as hypertension, inheritance of the apolipoprotein E ɛ4 allele, coronary heart disease, diabetes mellitus, ischaemic white matter lesions and generalised atherosclerosis. These findings may reflect an overdiagnosis of Alzheimer’s disease in individuals with silent cerebrovascular disease or that cerebrovascular disease may affects the clinical expression of Alzheimer’s disease. Further possibilities include that Alzheimer’s disease may increase the risk of vascular disease or that vascular disease may stimulate the Alzheimer’s disease process. Similar mechanisms may also be involved in the pathogenesis of both disorders, such as disturbances in the renin-angiotensin system, apoptosis, and psychological stress.


Vascular Dementia Rotterdam Study Albumin Ratio Brovascular Disease Primary Degenerative Dementia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aronson MK, Ooi WL, Morgenstern H, Hafner A, Masur D, Crystal H, Frishman WH, Fisher D, Katzman R (1990) Women, myocardial infarction, and dementia in the very old. Neurology 40: 1102 – 1106PubMedGoogle Scholar
  2. Beard CM, Kokmen E, O’Brien PC, Ania BJ, Melton LJ 3rd (1997) Risk of Alzheimer’s disease among elderly patients with anemia: population-based investigations in Olmsted County, Minnesota. Ann Epidemiol 7: 219–224Google Scholar
  3. Blennow K, Skoog I (1999) Genetic testing for Alzheimer’s disease: How close is reality? Curr Opin Psychiatry 12: 487 – 493CrossRefGoogle Scholar
  4. Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol 19: 253 – 262PubMedCrossRefGoogle Scholar
  5. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR (1999) Alzheimer neuropathology alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58: 376 – 388PubMedCrossRefGoogle Scholar
  6. Eastwood R, Amaducci L, Brayne C, Broe T, Burns A, Copeland J, Dickens B, Goate A, Hachinski V, Henderson S, Jolles J, Morris J, Ritchie K, Roses A, Rossor M, Schellenberg G, Skoog I, Storandt M, Tallis R, Whitehouse P, Clark S, Evans I, Horton R, Sharp D (1996) The challenge of the dementias. Lancet 347: 1303 – 1307CrossRefGoogle Scholar
  7. Erkinjuntti T, Hachinski V (1993) Dementia post stroke. In: Physical medicine and rehabilitation: State of the art reviews, vol 7. Hanley & Belfus Inc, Philadelphia, pp 195 – 212Google Scholar
  8. Hall ED, Oostveen JA, Dunn E, Carter DB (1995) Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 135: 17 – 27Google Scholar
  9. Hardy J, Mann D, Wester P, Winblad B (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer’s disease. Neurobiol Aging 7: 489 – 502PubMedCrossRefGoogle Scholar
  10. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF (1998) Cerebral infarcts in patients with autopsy-proven Alzheimer’s disease: CERAD, part XVIII. Consortium to establish a registry for Alzheimer’s disease. Neurology 51: 159 – 162PubMedGoogle Scholar
  11. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 349: 151 – 154PubMedCrossRefGoogle Scholar
  12. Holmes C, Cairns N, Lantos P, Mann A (1999) Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174: 45 – 50PubMedCrossRefGoogle Scholar
  13. Jendroska K, Poewe W, Daniel SE, Pluess J, Iwerssen-Schmidt H, Paulsen J, Barthel S, Schelosky L, Cervós-Navarro J, DeArmond SJ (1995) Ischemic stress induces deposition of amyloid (3 immunoreactivity in human brain. Acta Neuropathol 90: 461-466 Kuriyama M, Takahashi K, Yamano T, Hokezu Y, Togo S, Osame M, Igakura T (1994) Low levels of serum apolipoprotein A I and A II in senile dementia. Jpn J Psychiat Neur 48: 589 – 593Google Scholar
  14. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O’Brien PC, Palumbo PJ (1997) Risk of dementia among persons with diabetes mellitus: A population-based cohort study. Am J Epidemiol 145: 301-308 Lim A, Tsuang D, Kukull W, Nochlin D, Leverenz J, McCormick W, Bowen J, Teri L, Thompson J, Peskind ER, Raskind M, Larson EB (1999) Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am Geriatr Soc 47: 564 – 569Google Scholar
  15. Mari D, Parnetti L, Coppola R, Bottasso B, Reboldi GP, Senin U, Mannucci PM (1996) Hemostasis abnormalities in patients with vascular dementia and Alzheimer’s disease. Thromb Haemostasis 75: 216 – 218Google Scholar
  16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 34: 939 – 944PubMedGoogle Scholar
  17. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Joachim C, Litchfield S, Barnetson L, Smith AD (1997) The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 56: 165 – 170PubMedCrossRefGoogle Scholar
  18. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, Renaud S, Breteler MB (1997) Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 153: 185 – 192Google Scholar
  19. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MMB (1996) Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 39: 1392 – 1397PubMedCrossRefGoogle Scholar
  20. Ott A, Breteler MMB, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A (1997) Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 28: 316 – 321PubMedCrossRefGoogle Scholar
  21. Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, van Duijn CM, Breteler MM (1998) Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study. Lancet 351: 1840 – 1843PubMedCrossRefGoogle Scholar
  22. Pasquier F, Leys D (1997) Why are stroke patients prone to develop dementia? J Neurol 244: 135 – 142PubMedCrossRefGoogle Scholar
  23. Pennypacker KR, Hernandez H, Benkovic S, Morgan DG, Willing AE, Sanberg PR (1999) Induction of presenilins in the rat brain after middle cerebral arterial occlusion. Brain Res Bull 48: 539 – 543PubMedCrossRefGoogle Scholar
  24. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O’Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS- AIREN international workshop. Neurology 43: 250 – 260PubMedGoogle Scholar
  25. Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SR (1998) Altered plasma antioxidant status in subjects with Alzheimer’s disease and vascular dementia. Int J Geriatr Psychiatry 13: 840-845 Skoog I (1994) Risk factors for vascular dementia. A review. Dementia 5: 137–144 Skoog I (1997) Blood pressure and dementia. In: Hansson L, Birkenhager WH (eds), Handbook of hypertension, vol 18. Assessment of hypertensive organ damage. Elsevier Science, Amsterdam, pp 303 – 331Google Scholar
  26. Skoog I (1998) Guest editorial. Status of risk factors for vascular dementia. Neuroepidemiology 17: 2 – 9PubMedCrossRefGoogle Scholar
  27. Skoog I (1999a) The interaction between vascular disorders and Alzheimer’s disease. In: Iqbal K, Swaab DF, Winblad B, Wisniewski HM (eds), Alzheimer’s disease and related disorders: etiology, pathogenesis and therapeutics. John Wiley, Chichester, pp 523 – 530Google Scholar
  28. Skoog I (1999b) Possibilities for secondary prevention of Alzheimer’s disease. In: Mayeux R, Christen Y (eds), The epidemiology of Alzheimer’s disease: from gene to prevention. Springer, Berlin Heidelberg New York Tokyo Skoog I, Gustafson D (1999) Hormone replacement therapy and dementia. J Epidemiol Biostat 4: 227 – 252Google Scholar
  29. Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A (1993) A population-based study of dementia in 85-year-olds. N Engl J Med 328: 153 – 158PubMedCrossRefGoogle Scholar
  30. Skoog I, Palmertz B, Andreasson L-A (1994) The prevalence of white matter lesions on computed tomography of the brain in demented and non-demented 85-year-olds. J Geriatr Psychiatry Neurol 7: 169 – 175PubMedGoogle Scholar
  31. Skoog I, Vanmechelen E, Andreasson L-A, Palmertz B, Davidsson P, Hesse C, Blennow K (1995) A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration 4: 433 – 442PubMedCrossRefGoogle Scholar
  32. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, Persson G, Oden A, Svanborg A (1996) A 15-year longitudinal study on blood pressure and dementia. Lancet 347: 1141 – 1145PubMedCrossRefGoogle Scholar
  33. Skoog I, Hesse C, Fredman P, Andreasson L-A, Palmertz B, Blennow K (1997) Apolipoprotein E in cerebrospinal fluid in 85-year-olds. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white-matter lesions. Arch Neurol 54: 267 – 272Google Scholar
  34. Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karlsson I, Gottfries CG, Blennow K (1998) A population-study on blood-brain barrier function in 85-year-olds. Relation to Alzheimer’s disease and vascular dementia. Neurology 50: 966 – 971PubMedGoogle Scholar
  35. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277: 813 – 817PubMedCrossRefGoogle Scholar
  36. Soneira CF, Scott TM (1996) Severe cardiovascular disease and Alzheimer’s disease: Senile plaque formation in cortical areas. Clin Anat 9: 118 – 127PubMedCrossRefGoogle Scholar
  37. Sparks DL, Hunsaker III JC, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR (1990) Cortical senile plaques in coronary artery disease, aging and Alzheimer’s disease. Neurobiol Aging 11: 601 – 607PubMedCrossRefGoogle Scholar
  38. Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker III JC (1995) Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 131: 162 – 169PubMedCrossRefGoogle Scholar
  39. Suo Z, Humphrey J, Kundtz A, Sethi F, Placzek A, Crawford F, Mullan M (1998) Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo. Neurosci Lett 257: 77 – 80PubMedCrossRefGoogle Scholar
  40. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M (1996) β-amyloid-mediatedGoogle Scholar
  41. vasoactivity and vascular endothelial damage. Nature 380: 168–171 Wisniewski HM, Kozlowski PB (1982) Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). Ann NY Acad Sci 396: 119–131Google Scholar

Copyright information

© Springer-Verlag 2000

Authors and Affiliations

  • Ingmar Skoog
    • 1
    • 2
  1. 1.Institute of Clinical Neuroscience, Section of PsychiatrySahlgrenska Hospital, Güteborg UniversityGüteborgSweden
  2. 2.Department of PsychiatrySahlgrenska University HospitalSE-413 45 GüteborgSweden

Personalised recommendations